Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cazzola, M.
Right arrow Articles by Ascari, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cazzola, M.
Right arrow Articles by Ascari, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Natural history of idiopathic refractory sideroblastic anemia

M Cazzola, G Barosi, PG Gobbi, R Invernizzi, A Riccardi and E Ascari

Department of Internal Medicine and Medical Therapy, University of Pavia School of Medicine, Italy.

We analyzed the natural history of idiopathic refractory sideroblastic anemia (IRSA) in 37 patients studied between 1969 and 1986. Although erythroid abnormalities were prominent in all, 12 patients also showed involvement of the granulocytic and/or megakaryocytic cell lines, and nonrandom chromosomal aberrations were observed in five of 23 patients studied for such defects. Measurements of erythroid marrow function showed in most cases erythroid expansion with ineffective erythropoiesis. In seven patients, however, the erythroid activity was found to be inappropriately low for the degree of anemia. Transfusion dependence occurred in 26 of 37 cases. Iron overload was a common feature at presentation but produced clinical manifestations of hemochromatosis only in those patients who subsequently had a regular need for blood transfusions. Five patients progressed to bone marrow failure, and another five patients (two of whom had monosomy 7) evolved into acute nonlymphocytic leukemia (ANLL). The median survival was 72 months, with a high transfusion requirement, multilineage defects, and inappropriately low erythroid proliferation being associated with a poor prognosis. The most common causes of death were complications of iron overload and evolution into ANLL. We conclude that (a) the natural history of IRSA is characterized by an initial phase of erythroid hyperplasia and ineffective erythropoiesis, which is usually stable for many years but in a subset of patients may be followed by a phase of marrow failure with or without the later emergence of leukemic blasts; (b) peripheral blood counts, measurement of erythroid marrow function, and chromosomal analysis are useful for identifying subjects at risk of evolution into marrow failure or ANLL; and (c) IRSA patients with no need for blood transfusions are very likely to be long survivors, whereas those who become transfusion dependent are at risk of death from the complications of secondary hemochromatosis.

Volume 71, Issue 2, pp. 305-312, 02/01/1988
Copyright © 1988 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ASH Education BookHome page
E. Hellstrom-Lindberg and M. Cazzola
The Role of JAK2 Mutations in RARS and Other MDS
Hematology, January 1, 2008; 2008(1): 52 - 59.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. Cazzola, M. G. Della Porta, and L. Malcovati
Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes
Hematology, January 1, 2008; 2008(1): 166 - 175.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
L. Malcovati, M. G. Della Porta, C. Pascutto, R. Invernizzi, F. Passamonti, L. Arcaini, M. Maffioli, E. Rumi, E. Travaglino, P. Bernasconi, et al.
The Effect of Transfusion Dependency and Secondary Iron Overload on Survival of Patients with Myelodysplastic Syndrome.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 791 - 791.
[Abstract]


Home page
RadiologyHome page
D. B. Salem, J.-P. Cercueil, F. Ricolfi, and D. Krause
Case 75: Erythropoietic Hemochromatosis
Radiology, October 1, 2004; 233(1): 116 - 119.
[Full Text] [PDF]


Home page
BloodHome page
M. Cazzola, R. Invernizzi, G. Bergamaschi, S. Levi, B. Corsi, E. Travaglino, V. Rolandi, G. Biasiotto, J. Drysdale, and P. Arosio
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia
Blood, March 1, 2003; 101(5): 1996 - 2000.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
E. Beutler, A. V. Hoffbrand, and J. D. Cook
Iron Deficiency and Overload
Hematology, January 1, 2003; 2003(1): 40 - 61.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Cazzola, F. Mercuriali, and C. Brugnara
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Blood, June 15, 1997; 89(12): 4248 - 4267.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1988 by American Society of Hematology         Online ISSN: 1528-0020